97067 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Blood coagulation or fibrinolysis factors Thrombomodulin
CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#2CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#3COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS USING A CD14 INHIBITOR
#4CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#5BLOOD READER SYSTEMS AND THERANOSTICS FOR BRAIN DAMAGE AND INJURY
#6TRANSGENIC CLONED PIG FOR XENOTRANSPLANTATION EXPRESSING HUMAN CD46 AND TBM GENES, IN WHICH PORCINE ENDOGENOUS RETROVIRUS ENVELOPE C IS NEGATIVE AND GGTA1, CMAH, iGb3s AND ß4GalNT2 GENES ARE KNOCKED OUT, AND METHOD FOR PREPARING SAME
#7Fusion proteins and antibodies targeting human red blood cell antigens
#8BLOOD READER SYSTEMS AND THERONOSTICS FOR BRAIN DAMAGE AND INJURY
#9Thrombin-thrombomodulin fusion proteins as a powerful anticoagulant
#10Thrombin-thrombomodulin fusion proteins as protein C activators
#11HIGHLY-PURIFIED SOLUBLE THROMBOMODULIN AND METHOD FOR PRODUCING SAME
#12Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent
#13Thrombomodulin variants and use thereof
#14Treatment of coagulopathy with hyperfibrinolysis
#15TREATMENT OF COAGULOPATHY WITH HYPERFIBRINOLYSIS
#16SEQUENCE OF 55 NEW FOUND PROTEINS AND THEIR APPLICATION
#17Method for producing high-purity soluble thrombomodulin
#18Highly-purified soluble thrombomodulin and method for producing same
#19Protein fusion constructs possessing thrombolytic and anticoagulant properties
#20TREATMENT OF COAGULOPATHY WITH HYPERFIBRINOLYSIS
#21Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#22COMPOSITIONS CONTAINING THROMBOMODULIN DOMAINS AND USES THEREOF
#23COMPOSITIONS AND METHODS OF USE FOR SOLUBLE THROMBOMODULIN VARIANTS
#24In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#25In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#26In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#27In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#28Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#29AGENT FOR THERAPY AND/OR IMPROVEMENT OF DISSEMINATED INTRAVASCULAR COAGULATION
#30Method for producing high-purity soluble thrombomodulin
#31Treating acute renal failure with soluble thrombomodulin variants
#32In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#33Thrombomodulin derivatives and conjugates
#34Methods of using novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
#35Polynucleotides encoding anticoagulant fusion proteins
#36Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#37Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues
#38Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
#39Lectin-like domain of thrombomodulin and its therapeutic use